Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 121B (TMEM121B) is a protein-coding gene found in humans (located on chromosome 22) and other mammals. Also known as Cat eye syndrome critical region protein 6 (CECR6), this protein is predicted to be a component of cellular membranes but its biological function remains uncharacterized. TMEM121B is listed among the genes in the Cat Eye Syndrome critical region, a chromosomal segment whose duplication causes syndromic features, suggesting a potential role in genetic disorders arising from chromosomal abnormalities. There is no evidence indicating TMEM121B is a therapeutic target, a functionally characterized channel/receptor/enzyme, or a current focus of targeted drug development. As such, it is best classified as an **uncharacterized membrane protein** with ambiguous function and uncertain disease relevance beyond chromosomal disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 121B (TMEM121B).